Search Results - "Martens, Forike K"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    DPD Testing Before Treatment With Fluoropyrimidines in the Amsterdam UMCs: An Evaluation of Current Pharmacogenetic Practice by Martens, Forike K, Huntjens, Daan W, Rigter, Tessel, Bartels, Meike, Bet, Pierre M, Cornel, Martina C

    Published in Frontiers in pharmacology (28-01-2020)
    “…The fluoropyrimidines (FP) (5-Fluorouracil, capecitabine, and tegafur) are commonly used anti-cancer drugs, but lead to moderate to severe toxicity in about…”
    Get full text
    Journal Article
  2. 2

    Reflection on modern methods: Revisiting the area under the ROC Curve by Janssens, A Cecile J W, Martens, Forike K

    Published in International journal of epidemiology (01-08-2020)
    “…The area under the receiver operating characteristic (ROC) curve (AUC) is commonly used for assessing the discriminative ability of prediction models even…”
    Get full text
    Journal Article
  3. 3

    Evaluation of polygenic risk models using multiple performance measures: a critical assessment of discordant results by Martens, Forike K., Tonk, Elisa C. M., Janssens, A. Cecile J. W.

    Published in Genetics in medicine (01-02-2019)
    “…Purpose The area under the receiver operating characteristic curve (AUC) is commonly used for evaluating the improvement of polygenic risk models and…”
    Get full text
    Journal Article
  4. 4

    Small improvement in the area under the receiver operating characteristic curve indicated small changes in predicted risks by Martens, Forike K, Tonk, Elisa C.M, Kers, Jannigje G, Janssens, A. Cecile J.W

    Published in Journal of clinical epidemiology (01-11-2016)
    “…Abstract Objective Adding risk factors to a prediction model often increases the area under the receiver operating characteristic curve (AUC) only slightly,…”
    Get full text
    Journal Article
  5. 5

    External validation is only needed when prediction models are worth it (Letter commenting on: J Clin Epidemiol. 2015;68:25-34) by Martens, Forike K, Kers, Jannigje G, Janssens, A. Cecile J.W

    Published in Journal of clinical epidemiology (2016)
    “…[...]many of the remaining 41 studies (62 minus 21) that were not externally validated may not have been worth validating…”
    Get full text
    Journal Article
  6. 6
  7. 7

    How the Intended Use of Polygenic Risk Scores Guides the Design and Evaluation of Prediction Studies by Martens, Forike K., Janssens, A. Cecile J.W.

    Published in Current epidemiology reports (01-06-2019)
    “…Purpose of Review To explain how the intended use of polygenic risk scores (PRSs) in healthcare guides the design and evaluation of prediction studies. Recent…”
    Get full text
    Journal Article